Holen Sie sich die Stockscreener-App
18.36
3.92%
-0.75
Handel nachbörslich:
18.34
-0.02
-0.11%
Schlusskurs vom Vortag:
$19.11
Offen:
$19.065
24-Stunden-Volumen:
1.89M
Relative Volume:
0.59
Marktkapitalisierung:
$4.37B
Einnahmen:
$474.17M
Nettoeinkommen (Verlust:
$208.93M
KGV:
21.62
EPS:
0.8493
Netto-Cashflow:
$65.61M
1W Leistung:
-5.80%
1M Leistung:
-4.28%
6M Leistung:
+1.10%
1J Leistung:
+4.97%
1-Tages-Spanne:
$18.32
$19.19
1-Wochen-Bereich:
$18.32
$19.68
52-Wochen-Spanne:
$13.76
$25.67
Adma Biologics Inc Stock (ADMA) Company Profile
Firmenname
Adma Biologics Inc
Sektor
Branche
Telefon
(201) 478-5552
Adresse
C/O ADMA BIOLOGICS, INC., RAMSEY
Vergleichen Sie ADMA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ADMA
Adma Biologics Inc
|
18.36 | 4.55B | 474.17M | 208.93M | 65.61M | 0.8493 |
|
VRTX
Vertex Pharmaceuticals Inc
|
453.74 | 116.65B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
773.94 | 82.03B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.25 | 52.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
837.90 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
174.09 | 37.61B | 447.02M | -1.18B | -906.14M | -6.1812 |
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-07-19 | Fortgesetzt | Raymond James | Strong Buy |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2021-11-11 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-11-09 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-06-04 | Eingeleitet | Jefferies | Buy |
| 2019-04-15 | Bestätigt | H.C. Wainwright | Buy |
| 2019-02-07 | Fortgesetzt | H.C. Wainwright | Buy |
| 2017-12-11 | Bestätigt | Maxim Group | Buy |
| 2017-11-14 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2017-01-23 | Hochstufung | Maxim Group | Hold → Buy |
| 2016-08-01 | Herabstufung | Maxim Group | Buy → Hold |
| 2016-07-25 | Bestätigt | Maxim Group | Buy |
| 2015-05-13 | Bestätigt | Maxim Group | Buy |
| 2014-12-08 | Eingeleitet | Oppenheimer | Outperform |
| 2014-12-01 | Bestätigt | Maxim Group | Buy |
Alle ansehen
Adma Biologics Inc Aktie (ADMA) Neueste Nachrichten
ADMA Biologics stock slides nearly 4% as biotech weakens in thin year-end trade - ts2.tech
ANI Stock Is Up 49% This Past Year, Revenue Is Surging, and One Fund Still Walked Away - The Motley Fool
Harbor Capital Advisors Inc. Buys Shares of 59,801 ADMA Biologics Inc $ADMA - MarketBeat
Rice Hall James & Associates LLC Has $4.75 Million Stake in ADMA Biologics Inc $ADMA - MarketBeat
Brokers Suggest Investing in Adma Biologics (ADMA): Read This Before Placing a Bet - MSN
(ADMA) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
High Growth Tech Stocks To Watch In US December 2025 - simplywall.st
The Bull Case For ADMA Biologics (ADMA) Could Change Following Its Higher 2025 Revenue Outlook Revision - Sahm
Adma Biologics Receives Upgraded Price Target on Strong Outlook - AD HOC NEWS
Assessing ADMA Biologics (ADMA) Valuation After Its Upgraded 2025 Revenue Guidance - Sahm
ADMA Biologics (ADMA): Firm updates 2025 revenue guidance - MSN
ADMA Biologics Inc $ADMA Shares Bought by Voya Investment Management LLC - MarketBeat
Texas Permanent School Fund Corp Has $1.87 Million Holdings in ADMA Biologics Inc $ADMA - MarketBeat
ADMA Biologics (ADMA): Firm Updates 2025 Revenue Guidance - Finviz
Should You Be Adding ADMA Biologics (NASDAQ:ADMA) To Your Watchlist Today? - Yahoo Finance
How ADMA Biologics Inc. stock valuations compare to rivalsJuly 2025 Breakouts & Verified Swing Trading Watchlists - Улправда
Fed Meeting: Will ADMA Biologics Inc. stock outperform growth indexes2025 Pullback Review & Long-Term Growth Stock Strategies - Улправда
Published on: 2025-12-21 05:20:22 - Улправда
Perpetual Ltd Cuts Stake in ADMA Biologics Inc $ADMA - MarketBeat
Jobs Data: How ADMA Biologics Inc. stock valuations compare to rivalsPortfolio Gains Report & Advanced Technical Analysis Signals - Улправда
Will ADMA Biologics Inc. stock gain from lower inflationJuly 2025 Reactions & Risk Controlled Stock Pick Alerts - DonanımHaber
Published on: 2025-12-19 13:57:53 - Улправда
Decliners Report: Can ADMA Biologics Inc. stock sustain free cash flow growth2025 Winners & Losers & Low Risk High Reward Ideas - DonanımHaber
Can ADMA Biologics Inc. stock sustain revenue growthWeekly Loss Report & Low Volatility Stock Suggestions - Улправда
What analyst consensus says on ADMA Biologics Inc. stock2025 Valuation Update & Fast Gaining Stock Reports - Улправда
CEO Grossman Sells 21,000 ($415.6K) Of Adma Biologics Inc [ADMA] - TradingView — Track All Markets
ADMA Biologics (ADMA) CEO trades stock under Rule 10b5-1 plan - Stock Titan
Is ADMA Biologics (ADMA) Outperforming Other Medical Stocks This Year? - MSN
Thrivent Financial for Lutherans Raises Stock Holdings in ADMA Biologics Inc $ADMA - MarketBeat
Does ADMA’s Upgraded EPS Outlook And Higher-Yield Manufacturing Change The Bull Case For ADMA Biologics (ADMA)? - Sahm
ADMA Biologics Inc $ADMA Shares Purchased by Ranger Investment Management L.P. - MarketBeat
Cim LLC Acquires New Holdings in ADMA Biologics Inc $ADMA - MarketBeat
Precision Trading with Adma Biologics Inc (ADMA) Risk Zones - Stock Traders Daily
ADMA Biologics Inc $ADMA Holdings Decreased by AWM Investment Company Inc. - MarketBeat
The Play On ADMA Biologics: A Discounted Stock With Good Prospects (NASDAQ:ADMA) - Seeking Alpha
Here's Why Adma Biologics (ADMA) Fell More Than Broader Market - MSN
Is ADMA Biologics (ADMA) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Osterweis Capital Management Inc. Takes $5.40 Million Position in ADMA Biologics Inc $ADMA - MarketBeat
ADMA Biologics Inc $ADMA Shares Purchased by Marathon Capital Management - MarketBeat
Federated Hermes Inc. Has $17.06 Million Stake in ADMA Biologics Inc $ADMA - MarketBeat
Arrowstreet Capital Limited Partnership Cuts Stake in ADMA Biologics Inc $ADMA - MarketBeat
ADMA Biologics (ADMA) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Ophir Asset Management Pty Ltd Boosts Position in ADMA Biologics Inc $ADMA - MarketBeat
Ardsley Advisory Partners LP Has $7.28 Million Stock Holdings in ADMA Biologics Inc $ADMA - MarketBeat
WINTON GROUP Ltd Has $4.97 Million Stock Position in ADMA Biologics Inc $ADMA - MarketBeat
Will ASCENIV Momentum and FDA-Cleared Yield Gains Change ADMA Biologics' (ADMA) Narrative? - Sahm
Is ADMA Biologics Inc a good long term investmentLong-Term Growth Stocks & You’ve Never Seen Stock Picks Like These - earlytimes.in
What analysts say about ProShares Trust ProShares Ultra Financials stockHigh Yield Income Stocks & Small Investment Capital Gains - earlytimes.in
Adma Biologics (ADMA) Up 43.3% Since Last Earnings Report: Can It Continue? - sharewise.com
Stonepine Capital Management LLC Sells 60,000 Shares of ADMA Biologics Inc $ADMA - MarketBeat
Are Options Traders Betting on a Big Move in ADMA Biologics Stock? - MSN
Finanzdaten der Adma Biologics Inc-Aktie (ADMA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.23%
0.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):